{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T18:52:19Z","timestamp":1793472739734,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005296","name":"Universit\u00e4tsklinikum Regensburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005296","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Human leukocyte concentrates recovered from leukocyte reduction system (LRS) chambers of the Trima Accel automated blood collection device are a by-product of platelet apheresis that is often used in research. The Trima Accel software was obligatorily updated in 2023 from version 6 to 7. Here, we investigated software-dependent differences in the cellular composition of LRS concentrates when performing apheresis with either plasma or platelet additive solution. When using plasma as suspension medium, the software update to Trima 7 led to higher fraction of B cells as revealed by flow cytometry. Compared to platelets-in-plasma collection, the total recovered volume and leukocyte density was significantly reduced when running Trima 7 software with platelet additive solution including a plasma rinseback. Moreover, the proportion of lymphocytes and monocytes in these products was lower, whereas the proportion of neutrophils and eosinophils was higher. Researchers working with leukocytes isolated from LRS chambers should be aware that performing apheresis with platelet additive solution alters the composition of their starting material, which could affect the interpretation of some experiments.<\/jats:p>","DOI":"10.1038\/s41598-025-04350-4","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:19:40Z","timestamp":1749183580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Platelet apheresis with additive solution and plasma rinseback affects the cellular composition of LRS chamber products"],"prefix":"10.1038","volume":"15","author":[{"given":"Katharina","family":"Kronenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Dormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Brosig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Pamler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.","family":"Geissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Offner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola","family":"Haehnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,6]]},"reference":[{"key":"4350_CR1","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/trf.15121","volume":"59","author":"G Boudreau","year":"2019","unstructured":"Boudreau, G. et al. Leukoreduction system chambers are a reliable cellular source for the manufacturing of T-cell therapeutics. Transfusion 59, 1300\u20131311 (2019).","journal-title":"Transfusion"},{"key":"4350_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2023.104795","volume":"395\u2013396","author":"FA Rocha","year":"2024","unstructured":"Rocha, F. A. et al. Development of a highly cytotoxic, clinical-grade virus-specific T cell product for adoptive T cell therapy. Cell Immunol. 395\u2013396, 104795 (2024).","journal-title":"Cell Immunol."},{"key":"4350_CR3","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1111\/j.1537-2995.2007.01233.x","volume":"47","author":"S N\u00e9ron","year":"2007","unstructured":"N\u00e9ron, S. et al. Characterization of mononuclear cells remaining in the leukoreduction system chambers of apheresis instruments after routine platelet collection: A new source of viable human blood cells. Transfusion 47, 1042\u20131049 (2007).","journal-title":"Transfusion"},{"key":"4350_CR4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jim.2012.07.005","volume":"384","author":"I Tiscornia","year":"2012","unstructured":"Tiscornia, I., S\u00e1nchez-Martins, V., Hern\u00e1ndez, A. & Bollati-Fogol\u00edn, M. Human monocyte-derived dendritic cells from leukoreduction system chambers after plateletpheresis are functional in an in vitro co-culture assay with intestinal epithelial cells. J. Immunol. Methods. 384, 164\u2013170 (2012).","journal-title":"J. Immunol. Methods."},{"key":"4350_CR5","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.imbio.2013.07.005","volume":"218","author":"IA Pfeiffer","year":"2013","unstructured":"Pfeiffer, I. A. et al. Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes. Immunobiology 218, 1392\u20131401 (2013).","journal-title":"Immunobiology"},{"key":"4350_CR6","unstructured":"Terumo, B. C. T. Trima Accel\u00ae Version 7 Automated Blood Collection System. Terumo BCT (2024)."},{"key":"4350_CR7","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/vox.12317","volume":"110","author":"GC Leitner","year":"2016","unstructured":"Leitner, G. C. et al. Additive solutions differentially affect metabolic and functional parameters of platelet concentrates. Vox Sang. 110, 20\u201326 (2016).","journal-title":"Vox Sang."},{"key":"4350_CR8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/vox.12172","volume":"107","author":"H Gulliksson","year":"2014","unstructured":"Gulliksson, H. Platelet storage media. Vox Sang. 107, 205\u2013212 (2014).","journal-title":"Vox Sang."},{"key":"4350_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000487513","volume":"45","author":"PF van der Meer","year":"2018","unstructured":"van der Meer, P. F. & de Korte, D. Platelet additive solutions: A review of the latest developments and their clinical implications. Transfus. Med. Hemother. 45, 98\u2013102 (2018).","journal-title":"Transfus. Med. Hemother."},{"issue":"Suppl 3","key":"4350_CR10","first-page":"S146","volume":"63","author":"KA Thomas","year":"2023","unstructured":"Thomas, K. A. et al. Comparison of platelet quality and function across apheresis collection platforms. Transfusion 63(Suppl 3), S146\u2013S158 (2023).","journal-title":"Transfusion"},{"key":"4350_CR11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1182\/blood-2018-09-873125","volume":"133","author":"JM Gansner","year":"2019","unstructured":"Gansner, J. M. et al. Plateletpheresis-associated lymphopenia in frequent platelet donors. Blood 133, 605\u2013614 (2019).","journal-title":"Blood"},{"key":"4350_CR12","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1111\/trf.15192","volume":"59","author":"M Rahmani","year":"2019","unstructured":"Rahmani, M. et al. CD4+ T-cell lymphopenia in frequent platelet donors who have ceased platelet donation for at least 1 year. Transfusion 59, 1644\u20131647 (2019).","journal-title":"Transfusion"},{"key":"4350_CR13","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1111\/trf.15441","volume":"59","author":"JM Gansner","year":"2019","unstructured":"Gansner, J. M. et al. Severe CD4+ T-cell lymphopenia is not observed in frequent plateletpheresis donors collected on the Fenwal Amicus. Transfusion 59, 2783\u20132787 (2019).","journal-title":"Transfusion"},{"key":"4350_CR14","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1111\/trf.16666","volume":"61","author":"L Thuer","year":"2021","unstructured":"Thuer, L. et al. Total platelet donation count and donation frequency are determinants of plateletpheresis-associated lymphopenia. Transfusion 61, 3161\u20133173 (2021).","journal-title":"Transfusion"},{"key":"4350_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/trf.16175","volume":"61","author":"J Zhao","year":"2021","unstructured":"Zhao, J. et al. Frequent platelet donation is associated with lymphopenia and risk of infections: A nationwide cohort study. Transfusion 61, 464\u2013473 (2021).","journal-title":"Transfusion"},{"key":"4350_CR16","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1111\/trf.17567","volume":"63","author":"RM Kaufman","year":"2023","unstructured":"Kaufman, R. M. et al. Risk factors for T-cell lymphopenia in frequent platelet donors: The BEST collaborative study. Transfusion 63, 2072\u20132082 (2023).","journal-title":"Transfusion"},{"key":"4350_CR17","doi-asserted-by":"publisher","first-page":"E2770","DOI":"10.1073\/pnas.1408792111","volume":"111","author":"RV Bruggner","year":"2014","unstructured":"Bruggner, R. V., Bodenmiller, B., Dill, D. L., Tibshirani, R. J. & Nolan, G. P. Automated identification of stratifying signatures in cellular subpopulations. Proc. Natl. Acad. Sci. USA 111, E2770\u2013E2777 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"4350_CR18","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/eji.201445369","volume":"45","author":"J Hengst","year":"2015","unstructured":"Hengst, J. et al. High-resolution determination of human immune cell signatures from fine-needle liver aspirates. Eur. J. Immunol. 45, 2154\u20132157 (2015).","journal-title":"Eur. J. Immunol."},{"key":"4350_CR19","doi-asserted-by":"crossref","unstructured":"Strasser EF, Weidinger T, Zimmermann R, Ringwald J, Eckstein R. Recovery of white blood cells and platelets from leukoreduction system chambers of Trima Accel and COBE Spectra plateletpheresis devices. Transfusion. ;47:1943\u20134 2007.","DOI":"10.1111\/j.1537-2995.2007.01461.x"},{"key":"4350_CR20","doi-asserted-by":"publisher","first-page":"28363","DOI":"10.1038\/s41598-024-80118-6","volume":"14","author":"J Naghinezhad","year":"2024","unstructured":"Naghinezhad, J. et al. Designing a linear accelerator-based \u201cX irradiation system\u201d for platelet products: An efficient, safe, accessible and cost-effective alternative for conventional X- or gamma irradiators. Sci Rep. 14, 28363 (2024).","journal-title":"Sci Rep."},{"key":"4350_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1182\/blood.V48.3.361.361","volume":"48","author":"A Zipursky","year":"1976","unstructured":"Zipursky, A., Bow, E., Seshadri, R. S. & Brown, E. J. Leukocyte density and volume in normal subjects and in patients with acute lymphoblastic leukemia. Blood 48, 361\u2013371 (1976).","journal-title":"Blood"},{"key":"4350_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/cyto.a.23371","volume":"93","author":"AJ Lee","year":"2018","unstructured":"Lee, A. J. et al. DAFi: A directed recursive data filtering and clustering approach for improving and interpreting data clustering identification of cell populations from polychromatic flow cytometry data. Cytometry A. 93, 597\u2013610 (2018).","journal-title":"Cytometry A."},{"key":"4350_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/eji.201545774","volume":"46","author":"F Mair","year":"2016","unstructured":"Mair, F. et al. The end of gating? An introduction to automated analysis of high dimensional cytometry data. Eur. J. Immunol. 46, 34\u201343 (2016).","journal-title":"Eur. J. Immunol."},{"key":"4350_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jim.2014.11.009","volume":"416","author":"MM Tremblay","year":"2015","unstructured":"Tremblay, M. M. & Houtman, J. C. TCR-mediated functions are enhanced in activated peripheral blood T cells isolated from leucocyte reduction systems. J. Immunol. Methods 416, 137\u2013145 (2015).","journal-title":"J. Immunol. Methods"},{"key":"4350_CR25","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/j.1537-2995.2006.01033.x","volume":"46","author":"AB Dietz","year":"2006","unstructured":"Dietz, A. B. et al. A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers. Transfusion 46, 2083\u20132089 (2006).","journal-title":"Transfusion"},{"key":"4350_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.tmrv.2009.11.004","volume":"24","author":"EF Strasser","year":"2010","unstructured":"Strasser, E. F. & Eckstein, R. Optimization of leukocyte collection and monocyte isolation for dendritic cell culture. Transfus. Med. Rev. 24, 130\u2013139 (2010).","journal-title":"Transfus. Med. Rev."},{"key":"4350_CR27","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41467-018-05167-8","volume":"9","author":"P Riquelme","year":"2018","unstructured":"Riquelme, P. et al. TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity. Nat. Commun. 9, 2858 (2018).","journal-title":"Nat. Commun."},{"key":"4350_CR28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0022-1759(01)00337-4","volume":"252","author":"S Ebner","year":"2001","unstructured":"Ebner, S. et al. Generation of large numbers of human dendritic cells from whole blood passaged through leukocyte removal filters: an alternative to standard buffy coats. J. Immunol. Methods 252, 93\u2013104 (2001).","journal-title":"J. Immunol. Methods"},{"key":"4350_CR29","unstructured":"Kronenberg, K., Riquelme, P. & Hutchinson, J. A. Standard protocols for immune profiling of peripheral blood leucocyte subsets by flow cytometry using DuraClone IM reagents. Protocol Exchange (2019)."},{"key":"4350_CR30","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1038\/s41467-021-21572-y","volume":"12","author":"JA Hutchinson","year":"2021","unstructured":"Hutchinson, J. A. et al. Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis. Nat. Commun. 12, 1439 (2021).","journal-title":"Nat. Commun."},{"key":"4350_CR31","doi-asserted-by":"publisher","first-page":"5417","DOI":"10.1038\/s41467-024-49094-3","volume":"15","author":"G Glehr","year":"2024","unstructured":"Glehr, G. et al. Restricting datasets to classifiable samples augments discovery of immune disease biomarkers. Nat. Commun. 15, 5417 (2024).","journal-title":"Nat. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04350-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04350-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:19:44Z","timestamp":1749183584000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-04350-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4350"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-04350-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]},"assertion":[{"value":"27 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human blood donors were reviewed and approved by Ethics Committee University of Regensburg (22-2780-101). All experiments were performed in accordance with relevant guidelines and regulations and in accordance with the Declaration of Helsinki. All participants gave full informed, written consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"19923"}}